Position history for Boston Trust Walden Corp's holdings in CHEMED CORP NEW
Boston Trust Walden Corp holds 221,241 shares of CHE (CHEMED CORP NEW), worth $94.7M as of 2025-Q4. The position was decreased (-5.6% shares). CHE represents 0.7% of Boston Trust Walden Corp's portfolio.
Current Value
$94.7M
Current Shares
221,241
Total Value Change
-$25.5M
Total Shares Change
-199
Other major holders of CHE: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 221,241 |
-5.6% |
| $94.7M |
| 0.7% |
| $430.82 |
0 |
| 2025-Q3 | Decreased | 234,466 | -5.2% | $105M | 0.8% | $451.51 | 0 |
| 2025-Q2 | Increased | 247,434 | +0.4% | $120.5M | 0.9% | $557.82 | 42 |
| 2025-Q1 | Increased | 246,351 | +1.7% | $151.6M | 1.1% | $603.50 | 49 |
| 2024-Q4 | Increased | 242,172 | +10.0% | $128.3M | 0.9% | $525.44 | 47 |
| 2024-Q3 | Decreased | 220,067 | -0.6% | $132.3M | 0.9% | $595.79 | 0 |
| 2024-Q2 | Increased | 221,440 | +5.3% | $120.1M | 0.9% | $539.17 | 45 |